The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fludeoxyglucose F 18 Injection Market Research Report 2024
Synopsis
Fludeoxyglucose F 18 Injection is used for positron emission tomography (PET), and uses the characteristics of abnormal glucose metabolism of lesions for localization diagnosis and evaluation. 1. Used for tumor PET imaging to evaluate the malignancy of suspected or confirmed cases. 2. Used for PET imaging of coronary artery disease and left ventricular dysfunction. Combined with other myocardial perfusion imaging, it is used to evaluate the myocardial activity of the left ventricle and the recoverability of myocardial systolic function in cases of left ventricular dysfunction. 3. It is used to determine the epilepsy focus in epilepsy patients related to abnormal glucose metabolism.
Global Fludeoxyglucose F 18 Injection market is projected to reach US$ 177.6 million in 2029, increasing from US$ 109 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fludeoxyglucose F 18 Injection market research.
Fludeoxyglucose F 18 Injection is currently the most widely used positron radioactive drug in clinical practice.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Fludeoxyglucose F 18 Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Isologic
Siemens(PETNet)
Yantai Dongcheng Biochemicals Co.,Ltd.
Hta Co., Ltd
Guangdong Cyclotron Medical Science Co., Ltd
HUAYI Technology
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
China Isotope & Radiation Corporation
Segment by Type
＜200 mCi/1mL
200-300 mCi/1mL
＞300 mCi/1mL
Segment by Application
Cancer
Heart Disease
Epilepsy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Fludeoxyglucose F 18 Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Fludeoxyglucose F 18 Injection is used for positron emission tomography (PET), and uses the characteristics of abnormal glucose metabolism of lesions for localization diagnosis and evaluation. 1. Used for tumor PET imaging to evaluate the malignancy of suspected or confirmed cases. 2. Used for PET imaging of coronary artery disease and left ventricular dysfunction. Combined with other myocardial perfusion imaging, it is used to evaluate the myocardial activity of the left ventricle and the recoverability of myocardial systolic function in cases of left ventricular dysfunction. 3. It is used to determine the epilepsy focus in epilepsy patients related to abnormal glucose metabolism.
Global Fludeoxyglucose F 18 Injection market is projected to reach US$ 177.6 million in 2029, increasing from US$ 109 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fludeoxyglucose F 18 Injection market research.
Fludeoxyglucose F 18 Injection is currently the most widely used positron radioactive drug in clinical practice.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Fludeoxyglucose F 18 Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Isologic
Siemens(PETNet)
Yantai Dongcheng Biochemicals Co.,Ltd.
Hta Co., Ltd
Guangdong Cyclotron Medical Science Co., Ltd
HUAYI Technology
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
China Isotope & Radiation Corporation
Segment by Type
＜200 mCi/1mL
200-300 mCi/1mL
＞300 mCi/1mL
Segment by Application
Cancer
Heart Disease
Epilepsy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Fludeoxyglucose F 18 Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Fludeoxyglucose F 18 Injection Market Overview
1.1 Product Overview and Scope of Fludeoxyglucose F 18 Injection
1.2 Fludeoxyglucose F 18 Injection Segment by Type
1.2.1 Global Fludeoxyglucose F 18 Injection Market Value Comparison by Type (2023-2029)
1.2.2 ＜200 mCi/1mL
1.2.3 200-300 mCi/1mL
1.2.4 ＞300 mCi/1mL
1.3 Fludeoxyglucose F 18 Injection Segment by Application
1.3.1 Global Fludeoxyglucose F 18 Injection Market Value by Application: (2023-2029)
1.3.2 Cancer
1.3.3 Heart Disease
1.3.4 Epilepsy
1.4 Global Fludeoxyglucose F 18 Injection Market Size Estimates and Forecasts
1.4.1 Global Fludeoxyglucose F 18 Injection Revenue 2018-2029
1.4.2 Global Fludeoxyglucose F 18 Injection Sales 2018-2029
1.4.3 Global Fludeoxyglucose F 18 Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Fludeoxyglucose F 18 Injection Market Competition by Manufacturers
2.1 Global Fludeoxyglucose F 18 Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Fludeoxyglucose F 18 Injection Average Price by Manufacturers (2018-2023)
2.4 Global Fludeoxyglucose F 18 Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Fludeoxyglucose F 18 Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fludeoxyglucose F 18 Injection, Product Type & Application
2.7 Fludeoxyglucose F 18 Injection Market Competitive Situation and Trends
2.7.1 Fludeoxyglucose F 18 Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fludeoxyglucose F 18 Injection Players Market Share by Revenue
2.7.3 Global Fludeoxyglucose F 18 Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fludeoxyglucose F 18 Injection Retrospective Market Scenario by Region
3.1 Global Fludeoxyglucose F 18 Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Fludeoxyglucose F 18 Injection Global Fludeoxyglucose F 18 Injection Sales by Region: 2018-2029
3.2.1 Global Fludeoxyglucose F 18 Injection Sales by Region: 2018-2023
3.2.2 Global Fludeoxyglucose F 18 Injection Sales by Region: 2024-2029
3.3 Global Fludeoxyglucose F 18 Injection Global Fludeoxyglucose F 18 Injection Revenue by Region: 2018-2029
3.3.1 Global Fludeoxyglucose F 18 Injection Revenue by Region: 2018-2023
3.3.2 Global Fludeoxyglucose F 18 Injection Revenue by Region: 2024-2029
3.4 North America Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
3.4.1 North America Fludeoxyglucose F 18 Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Fludeoxyglucose F 18 Injection Sales by Country (2018-2029)
3.4.3 North America Fludeoxyglucose F 18 Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
3.5.1 Europe Fludeoxyglucose F 18 Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Fludeoxyglucose F 18 Injection Sales by Country (2018-2029)
3.5.3 Europe Fludeoxyglucose F 18 Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Fludeoxyglucose F 18 Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Fludeoxyglucose F 18 Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Fludeoxyglucose F 18 Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
3.7.1 Latin America Fludeoxyglucose F 18 Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Fludeoxyglucose F 18 Injection Sales by Country (2018-2029)
3.7.3 Latin America Fludeoxyglucose F 18 Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Fludeoxyglucose F 18 Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Fludeoxyglucose F 18 Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Fludeoxyglucose F 18 Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fludeoxyglucose F 18 Injection Sales by Type (2018-2029)
4.1.1 Global Fludeoxyglucose F 18 Injection Sales by Type (2018-2023)
4.1.2 Global Fludeoxyglucose F 18 Injection Sales by Type (2024-2029)
4.1.3 Global Fludeoxyglucose F 18 Injection Sales Market Share by Type (2018-2029)
4.2 Global Fludeoxyglucose F 18 Injection Revenue by Type (2018-2029)
4.2.1 Global Fludeoxyglucose F 18 Injection Revenue by Type (2018-2023)
4.2.2 Global Fludeoxyglucose F 18 Injection Revenue by Type (2024-2029)
4.2.3 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Type (2018-2029)
4.3 Global Fludeoxyglucose F 18 Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Fludeoxyglucose F 18 Injection Sales by Application (2018-2029)
5.1.1 Global Fludeoxyglucose F 18 Injection Sales by Application (2018-2023)
5.1.2 Global Fludeoxyglucose F 18 Injection Sales by Application (2024-2029)
5.1.3 Global Fludeoxyglucose F 18 Injection Sales Market Share by Application (2018-2029)
5.2 Global Fludeoxyglucose F 18 Injection Revenue by Application (2018-2029)
5.2.1 Global Fludeoxyglucose F 18 Injection Revenue by Application (2018-2023)
5.2.2 Global Fludeoxyglucose F 18 Injection Revenue by Application (2024-2029)
5.2.3 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Application (2018-2029)
5.3 Global Fludeoxyglucose F 18 Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Isologic
6.1.1 Isologic Corporation Information
6.1.2 Isologic Description and Business Overview
6.1.3 Isologic Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Isologic Fludeoxyglucose F 18 Injection Product Portfolio
6.1.5 Isologic Recent Developments/Updates
6.2 Siemens(PETNet)
6.2.1 Siemens(PETNet) Corporation Information
6.2.2 Siemens(PETNet) Description and Business Overview
6.2.3 Siemens(PETNet) Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Siemens(PETNet) Fludeoxyglucose F 18 Injection Product Portfolio
6.2.5 Siemens(PETNet) Recent Developments/Updates
6.3 Yantai Dongcheng Biochemicals Co.,Ltd.
6.3.1 Yantai Dongcheng Biochemicals Co.,Ltd. Corporation Information
6.3.2 Yantai Dongcheng Biochemicals Co.,Ltd. Description and Business Overview
6.3.3 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
6.3.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments/Updates
6.4 Hta Co., Ltd
6.4.1 Hta Co., Ltd Corporation Information
6.4.2 Hta Co., Ltd Description and Business Overview
6.4.3 Hta Co., Ltd Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hta Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
6.4.5 Hta Co., Ltd Recent Developments/Updates
6.5 Guangdong Cyclotron Medical Science Co., Ltd
6.5.1 Guangdong Cyclotron Medical Science Co., Ltd Corporation Information
6.5.2 Guangdong Cyclotron Medical Science Co., Ltd Description and Business Overview
6.5.3 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
6.5.5 Guangdong Cyclotron Medical Science Co., Ltd Recent Developments/Updates
6.6 HUAYI Technology
6.6.1 HUAYI Technology Corporation Information
6.6.2 HUAYI Technology Description and Business Overview
6.6.3 HUAYI Technology Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 HUAYI Technology Fludeoxyglucose F 18 Injection Product Portfolio
6.6.5 HUAYI Technology Recent Developments/Updates
6.7 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
6.6.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Corporation Information
6.6.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
6.7.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.8 China Isotope & Radiation Corporation
6.8.1 China Isotope & Radiation Corporation Corporation Information
6.8.2 China Isotope & Radiation Corporation Description and Business Overview
6.8.3 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Product Portfolio
6.8.5 China Isotope & Radiation Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fludeoxyglucose F 18 Injection Industry Chain Analysis
7.2 Fludeoxyglucose F 18 Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fludeoxyglucose F 18 Injection Production Mode & Process
7.4 Fludeoxyglucose F 18 Injection Sales and Marketing
7.4.1 Fludeoxyglucose F 18 Injection Sales Channels
7.4.2 Fludeoxyglucose F 18 Injection Distributors
7.5 Fludeoxyglucose F 18 Injection Customers
8 Fludeoxyglucose F 18 Injection Market Dynamics
8.1 Fludeoxyglucose F 18 Injection Industry Trends
8.2 Fludeoxyglucose F 18 Injection Market Drivers
8.3 Fludeoxyglucose F 18 Injection Market Challenges
8.4 Fludeoxyglucose F 18 Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
